From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

When Should ICU Patients Be Transfused?

One of the most controversial issues in critical care medicine is the proper threshold for blood transfusion. This multicenter Canadian trial enrolled 838 patients without active bleeding and with hemoglobin levels of 9.0 g/dl or lower during their first 3 days in intensive care units. Patients were randomized to a "restrictive" strategy (i.e., transfuse when hemoglobin drops below 7.0 g/dl, maintaining a range of 7.0 to 9.0 g/dl) or a "liberal" strategy (i.e., transfuse when hemoglobin drops below 10.0 g/dl, maintaining a range of 10.0 to 12.0 g/dl).

The 30-day mortality rate was 18.7 percent with restrictive transfusion and 23.3 percent with liberal transfusion, a nonsignificant difference. However, in-hospital mortality was significantly lower in the restrictive group (22.2 percent vs. 28.1 percent, p=0.05). In addition, rates of myocardial infarction and pulmonary edema during intensive care were significantly lower with restrictive transfusion. Numerous other subgroups and outcomes were examined, and none favored the liberal strategy. The restrictive group received half as many units of blood as the liberal group (mean, 2.6 vs. 5.6).

Comment: This important study makes a strong case for generally withholding transfusions until the hemoglobin drops below 7.0 g/dl. However, a long list of criteria excluded many patients from this trial, and only a quarter of eligible patients were randomized. Clinicians should thus review the eligibility criteria in this study carefully before applying the results to their patients.

— AS Brett

Published in Journal Watch General Medicine February 12, 1999

Citation(s):

Hebert PC et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999 Feb 11 340 409-417.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Sign-In

Forgot your password? Login via Athens
or your institution

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1999. Massachusetts Medical Society. All rights reserved.